Fig. 1From: Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritisBaseline and 12-Week MSUS images after treatment with tofacitinib (GSUS and PDUS). Panels a and b show images of PIP3 and MCP1 in both B-mode and power Doppler before and after treatment with tofacitinibBack to article page